Table 2.
Platelet count and clinicopathological characteristics in CRC patients.
|
Variables |
platelet (n = 90) | ||||
|---|---|---|---|---|---|
| Total | High (%) | Low (%) | N/A | P | |
| All patients | 90 | 45(100) | 44(100) | 1(100) | |
| Gender | 0.913 | ||||
| Males | 47 | 23 | 23 | 1 | |
| Females | 43 | 22 | 21 | 0 | |
| Age (years) | 0.545 | ||||
| < 60 | 30 | 16 | 13 | 1 | |
| ≥ 60 | 60 | 29 | 31 | 0 | |
| Depth of infiltrations | 0.314 | ||||
| T1+T2 | 12 | 4 | 7 | 1 | |
| T3+T4 | 78 | 41 | 37 | 0 | |
| Regional Lymph | 0 | 0.943 | |||
| N0 (negative) | 62 | 31 | 30 | 1 | |
| N1+N2 (positive) | 28 | 14 | 14 | 0 | |
| Distant metastasis | 0.544 | ||||
| M0 (negative) | 87 | 44 | 42 | 1 | |
| M1+M2 (positive) | 3 | 1 | 2 | 0 | |
| Length of Tumor (cm) | 0.730 | ||||
| < 5 | 37 | 19 | 17 | 1 | |
| ≥ 5 | 53 | 26 | 27 | 0 | |
| C5a+ Cells | 0.000 | ||||
| 1-3000 | 33 | 3 | 29 | 1 | |
| 3001-6000 | 28 | 16 | 12 | 0 | |
| > 6001 | 29 | 26 | 3 | 0 | |
| CD68+ Cells | 0.004 | ||||
| < 537 | 46 | 16 | 29 | 1 | |
| ≥ 537 | 44 | 29 | 15 | 0 | |
| CD68+PSGL-1+ Cells | 0.071 | ||||
| 0-300 | 54 | 22 | 31 | 1 | |
| 301-500 | 18 | 10 | 8 | 0 | |
| > 501 | 18 | 13 | 5 | 0 | |
| CD68+ PSGL-1+ C5/C5a+ Cells | 0.026 | ||||
| ≤ 220 | 45 | 17 | 27 | 1 | |
| > 221 | 45 | 28 | 17 | 0 | |